Goldman Sachs Maintains Buy on Calumet Specialty Prods, Raises Price Target to $19
Portfolio Pulse from Benzinga Newsdesk
Goldman Sachs analyst Neil Mehta has reaffirmed a Buy rating on Calumet Specialty Products Partners (NASDAQ:CLMT) and increased the price target from $17 to $19. This adjustment reflects a positive outlook on the company's future performance.
December 14, 2023 | 1:39 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Goldman Sachs analyst Neil Mehta maintains a Buy rating on Calumet Specialty Products Partners and raises the price target from $17 to $19, indicating a bullish outlook on the stock.
The increase in price target by a reputable analyst like Neil Mehta from Goldman Sachs typically signals confidence in the company's future performance and growth potential. This can positively influence investor sentiment and potentially lead to a short-term increase in the stock price as the market reacts to the new price target.
CONFIDENCE 90
IMPORTANCE 85
RELEVANCE 100